BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1357 related articles for article (PubMed ID: 12960117)

  • 21. Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia.
    Park JW; Hong JS; Lee KS; Kim HY; Lee JJ; Lee SR
    J Nutr Biochem; 2010 Nov; 21(11):1038-44. PubMed ID: 19962294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption, distribution, elimination of tea polyphenols in rats.
    Chen L; Lee MJ; Li H; Yang CS
    Drug Metab Dispos; 1997 Sep; 25(9):1045-50. PubMed ID: 9311619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.
    Wang P; Aronson WJ; Huang M; Zhang Y; Lee RP; Heber D; Henning SM
    Cancer Prev Res (Phila); 2010 Aug; 3(8):985-93. PubMed ID: 20628004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers.
    Ullmann U; Haller J; Decourt JD; Girault J; Spitzer V; Weber P
    Int J Vitam Nutr Res; 2004 Jul; 74(4):269-78. PubMed ID: 15580809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].
    Singh R; Akhtar N; Haqqi TM
    Life Sci; 2010 Jun; 86(25-26):907-18. PubMed ID: 20462508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E).
    Fu H; He J; Mei F; Zhang Q; Hara Y; Ryota S; Lubet RA; Chen R; Chen DR; You M
    Cancer Prev Res (Phila); 2009 Jun; 2(6):531-7. PubMed ID: 19470785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
    Lubet RA; Yang CS; Lee MJ; Hara Y; Kapetanovic IM; Crowell JA; Steele VE; Juliana MM; Grubbs CJ
    Mol Cancer Ther; 2007 Jul; 6(7):2022-8. PubMed ID: 17620432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis).
    Fung ST; Ho CK; Choi SW; Chung WY; Benzie IF
    Br J Nutr; 2013 Jun; 109(12):2199-207. PubMed ID: 23110850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins.
    Hao X; Sun Y; Yang CS; Bose M; Lambert JD; Ju J; Lu G; Lee MJ; Park S; Husain A; Wang S
    Nutr Cancer; 2007; 59(1):62-9. PubMed ID: 17927503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
    Gee JR; Saltzstein DR; Kim K; Kolesar J; Huang W; Havighurst TC; Wollmer BW; Stublaski J; Downs T; Mukhtar H; House MG; Parnes HL; Bailey HH
    Cancer Prev Res (Phila); 2017 May; 10(5):298-307. PubMed ID: 28325826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of green tea and its polyphenols on mouse liver.
    Saleh IG; Ali Z; Abe N; Wilson FD; Hamada FM; Abd-Ellah MF; Walker LA; Khan IA; Ashfaq MK
    Fitoterapia; 2013 Oct; 90():151-9. PubMed ID: 23892001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans.
    Kimura M; Umegaki K; Kasuya Y; Sugisawa A; Higuchi M
    Eur J Clin Nutr; 2002 Dec; 56(12):1186-93. PubMed ID: 12494303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols.
    Okabe S; Suganuma M; Hayashi M; Sueoka E; Komori A; Fujiki H
    Jpn J Cancer Res; 1997 Jul; 88(7):639-43. PubMed ID: 9310136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The green tea polyphenol (-)-epigallocatechin gallate and green tea can protect human cellular DNA from ultraviolet and visible radiation-induced damage.
    Morley N; Clifford T; Salter L; Campbell S; Gould D; Curnow A
    Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):15-22. PubMed ID: 15634219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress.
    Katiyar SK; Mukhtar H
    J Leukoc Biol; 2001 May; 69(5):719-26. PubMed ID: 11358979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.
    Yang F; de Villiers WJ; McClain CJ; Varilek GW
    J Nutr; 1998 Dec; 128(12):2334-40. PubMed ID: 9868178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green tea polyphenols affect skin preservation in rats and improve the rate of skin grafts.
    Kawazoe T; Kim H; Tsuji Y; Morimoto N; Hyon SH; Suzuki S
    Cell Transplant; 2008; 17(1-2):203-9. PubMed ID: 18468251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins.
    Kumar NB; Pow-Sang J; Spiess PE; Park J; Salup R; Williams CR; Parnes H; Schell MJ
    Oncotarget; 2016 Oct; 7(43):70794-70802. PubMed ID: 28053292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.